ClinicalMetric / Countries / Hungary / antineutrophil cytoplasmic antibody associated vasculitis
← 🇭🇺 Hungary Trials
🇭🇺 Hungary Country × Condition

antineutrophil cytoplasmic antibody associated vasculitis Clinical Trials in Hungary

Active clinical trials for antineutrophil cytoplasmic antibody associated vasculitis with research sites in Hungary. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 4 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇭🇺 Hungary

Active Trials in Hungary (1)

NCT06072482 Phase 4
Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Enrollment
300 pts
Country
🇭🇺 Hungary
Amgen
View Trial →

Frequently Asked Questions

How many antineutrophil cytoplasmic antibody associated vasculitis clinical trials are active in Hungary?
There are currently 1 active clinical trials for antineutrophil cytoplasmic antibody associated vasculitis with sites in Hungary, of which 1 are actively recruiting patients.
How can I join a antineutrophil cytoplasmic antibody associated vasculitis clinical trial in Hungary?
To join a antineutrophil cytoplasmic antibody associated vasculitis clinical trial in Hungary, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Hungary directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are antineutrophil cytoplasmic antibody associated vasculitis trials in Hungary?
Active antineutrophil cytoplasmic antibody associated vasculitis trials in Hungary span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Hungary Trials → Global antineutrophil cytoplasmic antibody associated vasculitis Trials → All Countries → All Trials →